Screener
Clarivate CLVT Life Sciences & Healthcare — Other Cost and Expense, Operating
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Clarivate in its filing.
Tagged under the XBRL concept us-gaap:OtherCostAndExpenseOperating.
The source filing: Clarivate’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001764046-26-000091
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Royalties and other product costs | (9.0) | (9.4) | (17.8) | (18.2) |
| Technology costs | (6.5) | (6.6) | (13.1) | (13.6) |
| Outside service costs | (1.7) | (3.0) | (3.7) | (5.6) |
| Other costs | (3.6) | (3.0) | (6.6) | (5.5) |
| LS&H Adjusted EBITDA | $24.3 | $32.2 | $53.5 | $62.8 |
| Total Reportable Segments | ||||
| Revenues | $587.3 | $621.4 | $1,172.8 | $1,215.1 |
| People-related costs | (196.5) | (204.0) | (398.7) | (409.7) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Clarivate's life sciences & healthcare — other cost and expense, operating?
- Clarivate (CLVT) reported life sciences & healthcare — other cost and expense, operating of $3.6M in Q2 2026.
- How has Clarivate's life sciences & healthcare — other cost and expense, operating changed year-over-year?
- Clarivate's life sciences & healthcare — other cost and expense, operating increased by 20.0% year-over-year, from $3M to $3.6M.
- What is the long-term trend for Clarivate's life sciences & healthcare — other cost and expense, operating?
- Over 3 years (2022 to 2025), Clarivate's life sciences & healthcare — other cost and expense, operating has grown at a -8.8% compound annual growth rate (CAGR), from $13.7M to $10.4M.
- What does life sciences & healthcare — other cost and expense, operating mean?
- This captures miscellaneous operating costs not categorized under personnel, technology, or royalties within the segment. It is used to monitor overhead efficiency and identify non-core expenditures that impact the segment's overall operating margin.
Ask your AI about Clarivate's life sciences & healthcare — other cost and expense, operating.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude